Andrea Drucker joins Insmed as general counsel
This article was originally published in Scrip
Insmed has appointed Andrea Drucker to the newly created role of senior vice-president, general counsel and corporate secretary. Ms Drucker will report to Timothy Whitten, Insmed's president and CEO. She most recently served as senior vice-president, general counsel and secretary for PuriCore, a publically-traded biotechnology company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.